Learning Objectives: Address overall patient well-being, including the effects of disease burden and medication burden, when choosing IgAN therapies Apply the latest clinical trial data on newer IgAN therapies presented at the 63rd European Renal Association (ERA) Congress to optimize their integration into clinical practice Assess the mechanism of action of newer IgAN therapies and how their effects on proteinuria and eGFR relate to potential disease-modifying benefits vs symptom control Participate effectively in multidisciplinary care team decision-making to improve early recognition, diagnosis, and management of IgAN
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 384 Inverness Parkway
Pricing
All courses included · from $18.75/mo
Courses are included in the subscription; some are also sold individually.
| Student Flex | $18.75/mo |
| Professional Flex | $60/mo |
| Student 3-Year | $100 |
| Student 2-Year | $112.50 |
+4 more plans
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Maternal-Fetal Medicine
- Medical Leadership & Administration
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Plastic & Reconstructive Surgery
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Surgical Oncology
- Thoracic Anesthesia
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Conference / congress
- includes Case-based learning
- includes Recorded-from-live session
- Credit · Up to 1.5 credits
- Commercial Support
-
ReleasedAug 17, 2026
-
Last day to claim creditAug 18, 2027 10 months left
-
American Kidney Fund +1 A New Paradigm in IgAN Management Advancing Clinical Practice in the Era of Therapeutic Expansion
-
PRIME Education, Inc. (PRIME®) Navigating New Guidelines in IgA Nephropathy
-
Medscape, LLC A New Chapter in IgA Nephropathy Care: Applying Evidence-Based Practices for B-Cell-Modulating Therapies
